Form D · Other Technology
U.S.BIONICS INC.
Emeryville, CA · CIK 0001860750
Offering snapshot reported May 11, 2021 · SEC filing
- Reported sold
- $5.13M Offering amount: $12M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 28, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 11, 2021 | Initial | $5,128,888 | No comparison | 3 | SEC filing |
| May 11, 2021 | Initial | $6,000,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-398945
The offering included the sale of up to 6,091,370 shares of Series A Preferred Stock at a price of $1.9704334 per share.
Source: Form D, filed May 11, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chun Tung Huang | Director |
| Homayoon Kazerooni | Director, Executive |
| Xiang (Shawn) Li | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
4512 Hollis Street
Emeryville, CA, 94608
Emeryville, CA, 94608